New drug stalls progression of disease for patients who have the BRCA genetic mutations, study by Sheba Medical Center with AstraZeneca and Merck shows

Israel's health expenditure is way below its OECD peers'. This leaves Startup Nation lacking beds, doctors, nurses, MRIs and CT scanners -- and looking to tech as a possible savior